With the more contagious delta variant of the coronavirus becoming prevalent in the United States, you may wonder how effective your COVID-19 vaccine is in fighting it.
A firm at the Pennsylvania Biotechnology Center says its new test can answer questions about the efficacy of your vaccine.
The test, called VaxEffect, was developed by the life science company FlowMetric which is housed inside the center, a nonprofit life sciences incubator. FlowMetric officially launched the test last week; it is available through health care providers.
“There are lots of vaccines out there . and you will create different immune responses potentially to those. When you re giving that many doses, millions around the country, there s a chance that you may not have received the dose you thought you were going to get. So it s really important for the individual to actually know that they generated immune response before they return to their every day life,” said Grant Morgan, general manager
How effective was your COVID-19 vaccine? A Bucks County biotech firm can answer that mcall.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mcall.com Daily Mail and Mail on Sunday newspapers.
The students pulled up to different lanes organized for them to do self-administered tests in their vehicles.
The tests were at no-cost to the students and they were scheduled in advance.
It s a necessary step for Neumann University to offer in-person learning in the spring semester.
MOVE IN DAY: Students at @NeumannUniv have to make One very important stop before moving into the dorms. The campus has partnered with @FlowDiag for a Mobile testing lab. #COVID results for students in 60 minutes. @6abcpic.twitter.com/JUIOsOJ20a TaRhonda Thomas (@TaRhondaThomas) January 15, 2021 Any student who is living on campus must show a negative COVID test before they can arrive and live on campus, said Dr. Chris Domes, Neumann University s President.
Philadelphia Man Becomes First Black Acceptant Into Groundbreaking Biotech Graduate Program at His University
Nafees Norris is on winter break.
The 26-year-old Philadelphia native just completed his first semester of graduate studies at Thomas Jefferson University.
But Norris is not just any student. And the Jefferson Institute of Bioprocessing (JIB) is not just any master’s course. The hybrid program opened in May 2019, becoming North America’s first specialized training institute for biopharmaceutical processing.
Norris became the first Black person accepted into the 12-month accelerated master’s program.
Biopharmaceutical processing is a rapidly expanding industry. Students in the JIB program learn gene therapy, protein replacement therapy and how to create vaccinations for pathogens such as COVID-19.